08:34 AM EDT, 04/25/2024 (MT Newswires) -- West Pharmaceutical Services ( WST ) reported Q1 adjusted earnings Thursday of $1.56 per diluted share, down from $1.98 a year earlier.

Analysts polled by Capital IQ expected $1.29.

Net sales for the quarter ended March 31 were $695.4 million, down from $716.6 million a year earlier.

Analysts surveyed by Capital IQ expected $671.7 million.

For full-year 2024, the company said it now expects adjusted EPS of $7.63 to $7.88, up from its prior outlook of $7.50 to $7.75. Analysts polled by Capital IQ expect $7.63.

Net sales for the year are still expected to be between $3 billion and $3.03 billion. Analysts polled by Capital IQ expect $3.01 billion.

The company's board maintained its quarterly dividend at $0.20 per share, payable Aug. 7 to shareholders of record as of July 31.

Price: 387.00, Change: +1.27, Percent Change: +0.33